Trip.com Group Ltd vs Zoetis Inc — how do they compare? Trip.com Group Ltd trades at $46.05 (market cap $29.10B), while Zoetis Inc trades at $75.11 (market cap $31.14B). The key difference: Trip.com Group Ltd and Zoetis Inc are close in size by market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| TCOM | ZTS | |
|---|---|---|
Market Cap | $29.10B | $31.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $78.96 | $156.76 |
52-Week Low | $39.84 | $71.91 |
Enterprise Value | $21.75B | $38.70B |
Dividend Yield | 0.42% | 2.81% |
Trailing returns across standard periods
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →